BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,844
$0.58
$2,810
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,844
$0.58
$2,810
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1
$5,000
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$7.61
$16,742
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$0.62
$4,361
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
5,200
$7.58
$39,426
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
500
$7.62
$3,810
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,688
$0.58
$2,719
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,688
$0.58
$2,719
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,688
$0.58
$2,719
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1
$5,000
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,375
$0.58
$2,538
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,375
$0.58
$2,538
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
5,000
$1
$5,000
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,375
$0.58
$2,538
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,000
$7.01
$7,010
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1
$5,000
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$7.13
$15,675
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$3.86
$26,985
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$3.86
$26,985
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
6,917
$0.58
$4,012
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
3,750
$0.58
$2,175
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
3,750
$0.58
$2,175
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
3,750
$0.58
$2,175
Purchase
DOW STEPHEN Mdirectordirector
Common Stock
5,800
$7.49
$43,465
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
2,500
$0.58
$1,450
Purchase
DOW STEPHEN Mdirectordirector
Common Stock
1,200
$7.2
$8,640
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
4,700
$5.13
$24,097
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
300
$1
$300
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
2,500
$0.58
$1,450
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
2,500
$0.58
$1,450
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
5,000
$4.1
$20,475
Purchase
DOW STEPHEN Mdirectordirector
Common Stock
19,162
$7.21
$138,120
Purchase
DOW STEPHEN Mdirectordirector
Common Stock
13,838
$7.21
$99,744
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
3,886
$0.58
$2,254
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$5.12
$35,840
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$5.12
$35,840
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$7.72
$16,973
Purchase
DOW STEPHEN Mdirectordirector
Common Stock
16,500
$8.61
$142,082
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
700
$8.35
$5,845
Purchase
DOW STEPHEN Mdirectordirector
Common Stock
8,500
$8.48
$72,106
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
6,600
$8.34
$55,031
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Non-Qualified Stock Option (right to buy)
7,500
$4.75
$35,618
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
16,000
$7.66
$122,528
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
601
$4.74
$2,846
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Non-Qualified Stock Option (right to buy)
17,500
$0.1
$1,750
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
20,000
$0.58
$11,600
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
20,000
$0.58
$11,600
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$8.47
$42,350
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Non-Qualified Stock Option (right to buy)
5,000
$8.47
$42,350
Showing 1200 to 1250 of 1267 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.